Cellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3d™ - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3d™ carriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing. We offer a range of products based on our versatile and easily functionalized platform for several applications, including next generation cell- and gene therapies. For more information, please visit www.cellevate.com
Looking for a particular Cellevate AB employee's phone or email?
The Cellevate AB annual revenue was $6 million in 2026.
Albin Jakobsson is the Founder and VP Production of Cellevate AB.
14 people are employed at Cellevate AB.
Cellevate AB is based in Lund, Skane.
The NAICS codes for Cellevate AB are [54171, 541713, 54, 5417, 541].
The SIC codes for Cellevate AB are [87, 873].